NIH-funded research NIH-funded research

Understanding how reactive astrocytes contribute to aging and neurodegenerative diseases

Official title: Function of reactive astrocytes in aging and neurodegenerative disease

Funded at Broad Institute, INC. · NIH-11080548 · Data updated 2026-11-12

This study is looking at how certain brain cells, called reactive astrocytes, change as we age and in diseases like Alzheimer's and Alexander Disease, to find out if understanding these changes can help us find better ways to treat these conditions.

More Aging research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBroad Institute, INC.
NIH-funded
Lab location1 site (Cambridge, United States)
Project startMay 1, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$93,197
NIH project number7K00AG068523-05
Project IDNIH-11080548 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease or Alexander Disease, particularly those experiencing significant symptoms.

Less likely to help

Patients with neurodegenerative diseases not related to astrocyte dysfunction or those in very advanced stages may not benefit from this research.

What this research studies

This research investigates the role of reactive astrocytes in the aging process and neurodegenerative diseases, particularly focusing on their behavior in conditions like Alzheimer's and Alexander Disease. The study aims to explore how these cells change in response to injury or inflammation, specifically looking at a protein called GFAP that is crucial for astrocyte function. By using both pharmacological and genetic methods, researchers will examine how certain enzymes affect the behavior of astrocytes in laboratory models and in mice that mimic human disease. This could lead to new insights into how to manage or treat these conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurodegenerative diseases, potentially improving outcomes for patients.

How similar studies have gone: Previous research has shown promising results in understanding the role of astrocytes in neurodegeneration, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Broad Institute, INC.
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Battaglia, Rachel — Broad Institute, INC.
  • Study coordinator: Battaglia, Rachel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.